Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
mycophenolic acid | active compound measured in certain mycophenolate exposure assessments | The mycophenolic acid report distinguishes the parent analyte from its glucuronide metabolite. | Objective | Drug levels - named analytes and exposure reports |
natriuresis | increased or measured urinary sodium excretion in context | The timed urine collection documented natriuresis after treatment. | Objective | Electrolytes, acid-base and metabolic testing |
nerve conduction study | measurement of electrical signals along peripheral nerves | Request a nerve conduction study identifying the symptomatic distribution. | Plan | Perioperative, diagnostic and follow-up actions |
new baseline | level of function or measurement now typical after change | Repeated measurements will help establish the new baseline after recovery. | Assessment | Diagnostic reasoning and strength of evidence |
nontarget lesion | disease site followed without inclusion in the target measurement total | Nontarget lesion was described separately from the measured lesions. | Assessment | Cancer, treatment response and transplant assessment |
norclozapine | clozapine metabolite measured in some monitoring panels | The norclozapine result is listed with its own units. | Objective | Drug levels - named analytes and exposure reports |
objective corroboration | measured or observed finding independently supports a reported change | Objective corroboration was provided by the repeat timed walk. | Assessment | Precision in clinical interpretation and documentation |
observed-to-predicted ratio | measured value divided by the model prediction at that time | The observed-to-predicted ratio was recalculated after the collection time was corrected. | Assessment | Drug concentrations, exposure and assay interpretation |
oliguric | associated with reduced measured urine output | The current kidney injury is oliguric over the documented interval. | Assessment | Volume, organ function and illness severity |
osmolar gap | difference between measured and calculated osmolality in usual clinical reporting | The consult records the osmolar gap and the calculation used. | Objective | Electrolytes, acid-base and metabolic testing |
oximetry | measurement of oxygen saturation | Obtain overnight oximetry as specified in the sleep evaluation. | Plan | Diagnostic procedures and specimen handling |
parathyroid hormone concentration | measured circulating hormone regulating calcium and phosphate | The parathyroid hormone concentration was assessed with concurrent calcium, phosphate and kidney function. | Objective | Glucose monitoring, endocrine testing and urine studies |
parent-to-metabolite ratio | parent drug concentration divided by the measured metabolite concentration | The parent-to-metabolite ratio was recorded with both analytes and collection times. | Assessment | Medication response, exposure and reconciliation |
| original compound measured separately from its metabolites | The parent drug and active metabolite appear on separate report lines. | Objective | Drug levels - analyte, specimen and reporting | |
pause | gap in electrical activity for a measured duration | The recording shows a 2.1-second pause overnight. | Objective | Tracings, rhythm and diagnostic measurements |
pharmacokinetic monitoring | review of dose, timing and measured exposure | The consult requests pharmacokinetic monitoring using actual administration times. | Plan | Drug levels - verification and documentation |
phenytoin | antiseizure medicine measured as free or total drug | The phenytoin result on the original report is explicitly labeled total. | Objective | Drug levels - named analytes and exposure reports |
plasma renin activity | measure of angiotensin I generation under specified assay conditions | Plasma renin activity was identified separately from a direct renin concentration. | Objective | Glucose monitoring, endocrine testing and urine studies |
plateau pressure | airway pressure measured during a passive end-inspiratory hold | The respiratory record lists plateau pressure and the ventilator settings. | Objective | Pulmonary function, ventilation and oxygen delivery |
platelet aggregation study | measurement of platelet response to selected activating agents | The platelet aggregation study was reviewed with recent antiplatelet exposure. | Objective | Coagulation, antibodies and hemostasis studies |
plethysmography | measurement of lung volumes or other physiologic volume changes | Body plethysmography was used to obtain static lung volumes. | Objective | Pulmonary function, ventilation and oxygen delivery |
post-hold level | drug concentration measured after therapy was held | The post-hold level was recorded with the time elapsed since the last confirmed dose. | Assessment | Medication response, exposure and reconciliation |
postductal saturation | oxygen saturation measured in a lower limb after the ductal connection | Postductal saturation was recorded from the foot during the same assessment. | Objective | Newborn examination, feeding and growth |
postprandial glucose | glucose measured after a meal | The log identifies the postprandial glucose as two hours after breakfast. | Objective | Electrolytes, acid-base and metabolic testing |
prealbumin | transthyretin measured in blood | The report lists prealbumin alongside the current inflammatory markers. | Objective | Hepatobiliary, pancreatic and nutrition findings |